NMax
Nov 13, 11:42 PM
$OGEN WARNING TO ORAGENICS MANAGEMENT: If this is repeated, you will almost definitely face prosecution:
How did a
$5,000 transaction potentially unlock MILLIONS of Oragenics shares?
Follow the money.
On July 2, 2025, Janet Huffman and the board of directors issued highly dilutive preferred shares amid extremely high
$OGEN short interest.
Here's the twist:
ONE preferred share could convert into 25 common shares!
With liquidity scarce, millions of new shares could suddenly become available, potentially providing an escape route for trapped shorts.
What triggered this?
A mere
$5,000 share issuance to Dawson James for advisory fees.
That transaction reportedly triggered an anti-dilution provision, slashing the Series H conversion price from
$2.50 to
$1.00.
The result? 25 common shares for EVERY preferred share.
Who benefited? Were recipients connected to short sellers?
$5,000. Millions of potential shares.
Who was this REALLY designed to benefit?
1 replies